Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis

Karla Teixeira Souza, Allan Andresson Lima Pereira, Raphael L. C. Araújo, Suilane Coelho Ribeiro Oliveira, Paulo M. Hoff, Rachel P. Riechelmann

ecancermedicalscience · 2016 · 20 citations · 29 references

DOIFull text

Open access

Abstract

Capecitabine is an acceptable and more convenient alternative to infusional 5-FU in the CRT for localised SCCAC, offering similar clinical CRR to those reported by phase-III trials.

References

29